[Edaily Reporter Shin Ha-yeon ] JETEMA Co.,Ltd.(216080)announced on the 10th that it has strengthened its academic marketing efforts in the Southeast Asian market by conducting academic programs in Thailand, including participation in academic conferences, sponsorship of cadaver workshops, and exclusive seminars.

Starting with its participation in the “2026 Korean Society of Aesthetic Plastic and Laser Surgery Thailand Academic Conference (ASLS BANGKOK 2026)” held in Bangkok, Thailand, JETEMA Co.,Ltd. served as the official main filler sponsor for the ASLS cadaver workshop and hosted an exclusive in-depth theoretical seminar on the PDO thread “Epiticon®.” The company shared clinical applications and procedural know-how for each product with medical professionals from Southeast Asian countries, including Thailand, Vietnam, and Indonesia.

At ASLS BANGKOK 2026, held on the 2nd and 3rd, the company set up its own booth to showcase its hyaluronic acid (HA) filler “e.p.t.q.®,” the botulinum toxin product “JETEMA Co.,Ltd. DerToxin Injection,” and the PDO thread “Epiticon®.”

During the academic sessions, Dr. Choi Ho-sung, Director of Leeul Clinic, introduced a combined contouring technique for the neck and shoulders using JETEMA Co.,Ltd.'s DerToxin Injection and e.p.t.q.®. Dr. Thanya, a Thai medical professional, shared treatment approaches and techniques involving the use of e.p.t.i.con in high-risk anatomical areas.

At the ASLS cadaver workshop held on the 4th, JETEMA Co.,Ltd. participated as the official main filler sponsor and supplied Epiticon products for both theoretical lectures and hands-on sessions. Approximately 80 medical professionals from Southeast Asian countries, including Vietnam and Indonesia, participated. Dr. Nam Hyun-seok, Director of the Songdo branch of Ohwoon Clinic, introduced filler injection techniques for the glabella and nose using Epitique, and participants gained relevant anatomical knowledge and product application skills through cadaver-based hands-on practice.

Academic activities focused on Epiticon also continued for local medical professionals in Thailand. On the 7th, JETEMA Co.,Ltd. held an in-depth theoretical seminar exclusively on Epiticon for key opinion leaders (KOLs) from major plastic surgery hospitals in Thailand. Dr. Jang Du-yeol, Director of Change Clinic, served as a speaker and explained the principles of product application and clinical approaches using Epiticon—which was launched in Thailand in the second half of 2024—for breast lifting procedures.

JETEMA Co.,Ltd. representative stated, “This academic event in Thailand is significant not only for raising awareness of our diverse product portfolio but also for expanding our engagement with local medical professionals through clinical training and in-depth academic programs tailored to the characteristics of each product.” The representative added, “We will continue to strengthen academic exchanges with local medical professionals in key Southeast Asian markets and consistently present differentiated academic content.”